Stroke Clinical Trial: Only 37% of Participants Are Female

Stroke Clinical Trial: Only 37% of Participants Are Female

Stroke clinical trial: only 37% of participants are female. A new analysis suggests that while the lifetime risk of stroke is equal among women and men, only 37% of participants in clinical trials of stroke treatments are female.

During a stroke, the blood supply to part of your brain is interrupted or reduced. Stroke prevents the affected region of oxygen and nutrients.

Symptoms of stroke can include numbness or weakness on one side of the body, difficulty speaking and understanding speech, and problems with vision.

According to the Centers for Disease Control and Prevention (CDC) stroke affects more than 795,000 every year in the United States. Someone has a stroke every 40 seconds, and every 4 minutes, someone dies from a stroke.

The study shows the global lifetime risk of stroke from age 25 onwards is around 25% among men and women.

The new research analyzed 281 trials of stroke treatments and involved a total of 588,887 participants. In the latest research found that 37.4% of the total 588,887 participants in the clinical trial were female.

“Our findings have implications for how women with stroke may be treated in the future, as women typically have worse functional outcomes after stroke and require more supportive care,” says study author Cheryl Carcel. “Making sure there are enough women in clinical studies to accurately reflect the proportion of women who have strokes may have implications for future treatment recommendations for women affected by this serious condition,” Dr. Carcel added.